BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND PTPRC, LCA, 5788, ENSG00000081237, T200, GP180, B220, LY5, CD45 AND Treatment
88 results:

  • 1. PD-L1 on large extracellular vesicles is a predictive biomarker for therapy response in tissue PD-L1-low and -negative patients with non-small cell lung cancer.
    Schöne N; Kemper M; Menck K; Evers G; Krekeler C; Schulze AB; Lenz G; Wardelmann E; Binder C; Bleckmann A
    J Extracell Vesicles; 2024 Mar; 13(3):e12418. PubMed ID: 38453684
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Resistance to BRAF inhibition explored through single circulating tumour cell molecular profiling in BRAF-mutant non-small-cell lung cancer.
    Mezquita L; Oulhen M; Aberlenc A; Deloger M; Aldea M; Honore A; Lecluse Y; Howarth K; Friboulet L; Besse B; Planchard D; Farace F
    Br J Cancer; 2024 Mar; 130(4):682-693. PubMed ID: 38177660
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Doxorubicin induced epigenetic regulation of dendritic cell maturation in association with T cell activation facilitates tumor protective immune response in non-small cell lung cancer (NSCLC).
    Mukherjee O; Paul S; Das S; Rakshit S; Shanmugam G; George M; Sarkar K
    Pathol Res Pract; 2024 Jan; 253():155004. PubMed ID: 38086291
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
    Zhao S; Li Y; Xu J; Shen L
    Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A humanized orthotopic mouse model for preclinical evaluation of immunotherapy in Ewing sarcoma.
    Luo W; Hoang H; Liao Y; Pan J; Ayello J; Cairo MS
    Front Immunol; 2023; 14():1277987. PubMed ID: 37868989
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Novel conditionally replicating adenovirus-mediated efficient detection of circulating tumor cells in lung cancer patients.
    Ikemoto S; Sakurai F; Tokuoka S; Yamashita T; Takayama K; Hoshi K; Okabe T; Sumiyoshi I; Togo S; Takahashi K; Tachibana M; Mizuguchi H
    PLoS One; 2023; 18(10):e0286323. PubMed ID: 37856461
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A PDA-Functionalized 3D lung Scaffold Bioplatform to Construct Complicated Breast Tumor Microenvironment for Anticancer Drug Screening and Immunotherapy.
    Zhang W; Chen Y; Li M; Cao S; Wang N; Zhang Y; Wang Y
    Adv Sci (Weinh); 2023 Sep; 10(26):e2302855. PubMed ID: 37424037
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A maladaptive pleural environment suppresses preexisting anti-tumor activity of pleural infiltrating T cells.
    Donnenberg VS; Luketich JD; Sultan I; Lister J; Bartlett DL; Ghosh S; Donnenberg AD
    Front Immunol; 2023; 14():1157697. PubMed ID: 37063842
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Proliferative ability of circulating tumor cells is a prognostic factor in Early-Stage lung adenocarcinoma.
    Che TF; Chiu CH; Wu YC; Chen JY; Chou TY; Cheng YC; Chiang CL; Huang CS; Tuang IS; Ho YH; Hong JH; Huang YJ; Ho HL; Chang YC
    Lung Cancer; 2023 Apr; 178():198-205. PubMed ID: 36871344
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Licochalcone A induces cell cycle arrest in human lung squamous carcinoma cells
    Fan X; Wang J; Wang L
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Jan; 43(1):111-116. PubMed ID: 36856218
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Construction of a Humanized PBMC-PDX Model to Study the Efficacy of a Bacterial Marker in lung cancer Immunotherapy.
    Wu C; Wang X; Shang H; Wei H
    Dis Markers; 2022; 2022():1479246. PubMed ID: 36072895
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Mechanism of miR-760 Reversing lung cancer Immune Escape by Downregulating IDO1 and Eliminating Regulatory T Cells Based on Mathematical Biology.
    Ge H; Wang L; Chen W; Wang L
    Comput Math Methods Med; 2022; 2022():2960773. PubMed ID: 35872931
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Targeting PIK3CA Actionable Mutations in the Circulome: A Proof of Concept in Metastatic Breast cancer.
    Cardinali B; De Luca G; Tasso R; Coco S; Garuti A; Buzzatti G; Sciutto A; Arecco L; Villa F; Carli F; Reverberi D; Quarto R; Dono M; Del Mastro L
    Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682999
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Chemotherapy Coupled to Macrophage Inhibition Induces T-cell and B-cell Infiltration and Durable Regression in Triple-Negative Breast cancer.
    Singh S; Lee N; Pedroza DA; Bado IL; Hamor C; Zhang L; Aguirre S; Hu J; Shen Y; Xu Y; Gao Y; Zhao N; Chen SH; Wan YW; Liu Z; Chang JT; Hollern D; Perou CM; Zhang XHF; Rosen JM
    Cancer Res; 2022 Jun; 82(12):2281-2297. PubMed ID: 35442423
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Pharmacologic ACE-Inhibition Mitigates Radiation-Induced Pneumonitis by Suppressing ACE-Expressing lung Myeloid Cells.
    Sharma GP; Fish BL; Frei AC; Narayanan J; Gasperetti T; Scholler D; Pierce L; Szalewski N; Blue N; Medhora M; Himburg HA
    Int J Radiat Oncol Biol Phys; 2022 May; 113(1):177-191. PubMed ID: 35093482
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Biosensors for circulating tumor cells (CTCs)-biomarker detection in lung and prostate cancer: Trends and prospects.
    Hussain SH; Huertas CS; Mitchell A; Deman AL; Laurenceau E
    Biosens Bioelectron; 2022 Feb; 197():113770. PubMed ID: 34768065
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Identification of potential target genes of non-small cell lung cancer in response to resveratrol treatment by bioinformatics analysis.
    Gao P; Ren G
    Aging (Albany NY); 2021 Oct; 13(19):23245-23261. PubMed ID: 34633989
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Exploration of the prognostic signature reflecting tumor microenvironment of lung adenocarcinoma based on immunologically relevant genes.
    Wu W; Jia L; Zhang Y; Zhao J; Dong Y; Qiang Y
    Bioengineered; 2021 Dec; 12(1):7417-7431. PubMed ID: 34612148
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Oxaliplatin facilitates tumor-infiltration of T cells and natural-killer cells for enhanced tumor immunotherapy in lung cancer model.
    Xin M; Lin D; Yan N; Li H; Li J; Huang Z
    Anticancer Drugs; 2022 Feb; 33(2):117-123. PubMed ID: 34561996
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Investigation of Biomarkers and Handling Strategy of Erlotinib-Induced Skin Rash in Rats.
    Julian I; Iwamoto T
    Biol Pharm Bull; 2021; 44(8):1050-1059. PubMed ID: 34334490
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.